The Journal of Cell Biology, Vol 118, 551-559, Copyright © 1992 by The Rockefeller University Press

ARTICLES

Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia

GM Denning, LS Ostedgaard and MJ Welsh
Howard Hughes Medical Institute, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a membrane glycoprotein that forms Cl- channels. Previous work has shown that when some CF- associated mutants of CFTR are expressed in heterologous cells, their glycosylation is incomplete. That observation led to the hypothesis that such mutants are not delivered to the plasma membrane where they can mediate Cl- transport. Testing this hypothesis requires localization of CFTR in nonrecombinant cells and a specific determination of whether CFTR is in the apical membrane of normal and CF epithelia. To test the hypothesis, we used primary cultures of airway epithelia grown on permeable supports because they polarize and express the CF defect in apical Cl- permeability. Moreover, their dysfunction contributes to disease. We developed a semiquantitative assay, using nonpermeabilized epithelia, an antibody directed against an extracellular epitope of CFTR, and large (1 microns) fluorescent beads which bound to secondary antibodies. We observed specific binding to airway epithelia from non-CF subjects, indicating that CFTR is located in the apical membrane. In contrast, there was no specific binding to the apical membrane of CF airway epithelia. These data were supported by qualitative studies using confocal microscopy: the most prominent immunostaining was in the apical region of non-CF cells and in cytoplasmic regions of CF cells. The results indicate that CFTR is either missing from the apical membrane of these CF cells or it is present at a much reduced level. The data support the proposed defective delivery of some CF-associated mutants to the plasma membrane and explain the lack of apical Cl- permeability in most CF airway epithelia.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Robert, R., Carlile, G. W., Pavel, C., Liu, N., Anjos, S. M., Liao, J., Luo, Y., Zhang, D., Thomas, D. Y., Hanrahan, J. W. (2008). Structural Analog of Sildenafil Identified as a Novel Corrector of the F508del-CFTR Trafficking Defect. Mol. Pharmacol. 73: 478-489 [Abstract] [Full Text]  
• Ostedgaard, L. S., Rogers, C. S., Dong, Q., Randak, C. O., Vermeer, D. W., Rokhlina, T., Karp, P. H., Welsh, M. J. (2007). Processing and function of CFTR-{Delta}F508 are species-dependent. Proc. Natl. Acad. Sci. USA 104: 15370-15375 [Abstract] [Full Text]  
• Pagant, S., Kung, L., Dorrington, M., Lee, M. C.S., Miller, E. A. (2007). Inhibiting Endoplasmic Reticulum (ER)-associated Degradation of Misfolded Yor1p Does Not Permit ER Export Despite the Presence of a Diacidic Sorting Signal. Mol. Biol. Cell 18: 3398-3413 [Abstract] [Full Text]  
• Dormer, R L, Harris, C M, Clark, Z, Pereira, M M C, Doull, I J M, Norez, C, Becq, F, McPherson, M A (2005). Sildenafil (Viagra) corrects {Delta}F508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. Thorax 60: 55-59 [Abstract] [Full Text]  
• Zhang, X.-M., Wang, X.-T., Yue, H., Leung, S. W., Thibodeau, P. H., Thomas, P. J., Guggino, S. E. (2003). Organic Solutes Rescue the Functional Defect in {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator. J. Biol. Chem. 278: 51232-51242 [Abstract] [Full Text]  
• Bertrand, C. A., Frizzell, R. A. (2003). The role of regulated CFTR trafficking in epithelial secretion. Am. J. Physiol. Cell Physiol. 285: C1-C18 [Abstract] [Full Text]  
• SELVADURAI, H. C., MCKAY, K. O., BLIMKIE, C. J., COOPER, P. J., MELLIS, C. M., VAN ASPEREN, P. P. (2002). The Relationship between Genotype and Exercise Tolerance in Children with Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 165: 762-765 [Abstract] [Full Text]  
• Dormer, R. L., Derand, R., McNeilly, C. M., Mettey, Y., Bulteau-Pignoux, L., Metaye, T., Vierfond, J.-M., Gray, M. A., Galietta, L. J. V., Morris, M. R., Pereira, M. M. C., Doull, I. J. M., Becq, F., McPherson, M. A. (2002). Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J. Cell Sci. 114: 4073-4081 [Abstract] [Full Text]  
• Gibson, G. A., Hill, W. G., Weisz, O. A. (2000). Evidence against the acidification hypothesis in cystic fibrosis. Am. J. Physiol. Cell Physiol. 279: C1088-C1099 [Abstract] [Full Text]  
• Kagan, A., Yu, Z., Fishman, G. I., McDonald, T. V. (2000). The Dominant Negative LQT2 Mutation A561V Reduces Wild-type HERG Expression. J. Biol. Chem. 275: 11241-11248 [Abstract] [Full Text]  
• Gerceker, A. A., Zaidi, T., Marks, P., Golan, D. E., Pier, G. B. (2000). Impact of Heterogeneity within Cultured Cells on Bacterial Invasion: Analysis of Pseudomonas aeruginosa and Salmonella enterica Serovar Typhi Entry into MDCK cells by Using a Green Fluorescent Protein-Labelled Cystic Fibrosis Transmembrane Conductance Regulator Receptor. Infect. Immun. 68: 861-870 [Abstract] [Full Text]  
• Massengale, A.R. D., Quinn, F. Jr., Yankaskas, J., Weissman, D., Thomas McClellan, W., Cuff, C., Aronoff, S. C. (1999). Reduced Interleukin-8 Production by Cystic Fibrosis Airway Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 20: 1073-1080 [Abstract] [Full Text]  
• Maldonado, A. M., de la Fuente, N., Portillo, F. (1998). Characterization of an Allele-Nonspecific Intragenic Suppressor in the Yeast Plasma Membrane H+-ATPase Gene (PMA1). Genetics 150: 11-19 [Abstract] [Full Text]  
• Zhu, Z.-B., Atkinson, T. P., Volanakis, J. E. (1998). A Novel Type II Complement C2 Deficiency Allele in an African-American Family. J. Immunol. 161: 578-584 [Abstract] [Full Text]  
• Latronico, A. C., Chai, Y., Arnhold, I. J.P., Liu, X., Mendonca, B. B., Segaloff, D. L. (1998). A Homozygous Microdeletion in Helix 7 of the Luteinizing Hormone Receptor Associated with Familial Testicular and Ovarian Resistance Is Due to Both Decreased Cell Surface Expression and Impaired Effector Activation by the Cell Surface Receptor. Mol. Endocrinol. 12: 442-450 [Abstract] [Full Text]  
• Brezillon, S., Zahm, J.-M., Pierrot, D., Gaillard, D., Hinnrasky, J., Millart, H., Klossek, J.-M., Tummler, B., Puchelle, E. (1997). ATP Depletion Induces a Loss of Respiratory Epithelium Functional Integrity and Down-regulates CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Expression. J. Biol. Chem. 272: 27830-27838 [Abstract] [Full Text]  
• Saunders, C., Limbird, L. E. (1997). Disruption of Microtubules Reveals Two Independent Apical Targeting Mechanisms for G-protein-coupled Receptors in Polarized Renal Epithelial Cells. J. Biol. Chem. 272: 19035-19045 [Abstract] [Full Text]  
• Cotten, J. F., Ostedgaard, L. S., Carson, M. R., Welsh, M. J. (1996). Effect of Cystic Fibrosis-associated Mutations in the Fourth Intracellular Loop of Cystic Fibrosis Transmembrane Conductance Regulator. J. Biol. Chem. 271: 21279-21284 [Abstract] [Full Text]  
• Sheppard, D. N., Travis, S. M., Ishihara, H., Welsh, M. J. (1996). Contribution of Proline Residues in the Membrane-spanning Domains of Cystic Fibrosis Transmembrane Conductance Regulator to Chloride Channel Function. J. Biol. Chem. 271: 14995-15001 [Abstract] [Full Text]  
• Qu, B.-H., Thomas, P. J. (1996). Alteration of the Cystic Fibrosis Transmembrane Conductance Regulator Folding Pathway. J. Biol. Chem. 271: 7261-7264 [Abstract] [Full Text]  
• Abell, A., Liu, X., Segaloff, D. L. (1996). Deletions of Portions of the Extracellular Loops of the Lutropin/Choriogonadotropin Receptor Decrease the Binding Affinity for Ovine Luteinizing Hormone, but Not Human Choriogonadotropin, by Preventing the Formation of Mature Cell Surface Receptor. J. Biol. Chem. 271: 4518-4527 [Abstract] [Full Text]  
• O'Riordan, C. R., Erickson, A., Bear, C., Li, C., Manavalan, P., Wang, K. X., Marshall, J., Scheule, R. K., McPherson, J. M., Cheng, S. H., Smith, A. E. (1995). Purification and Characterization of Recombinant Cystic Fibrosis Transmembrane Conductance Regulator from Chinese Hamster Ovary and Insect Cells. J. Biol. Chem. 270: 17033-17043 [Abstract] [Full Text]  
• Pasyk, E. A., Foskett, J. K. (1995). Mutant ([IMAGE]F508) Cystic Fibrosis Transmembrane Conductance Regulator Cl[IMAGE] Channel Is Functional When Retained in Endoplasmic Reticulum of Mammalian Cells. J. Biol. Chem. 270: 12347-12350 [Abstract] [Full Text]  
• Walker, J, Watson, J, Holmes, C, Edelman, A, Banting, G (1995). Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (CFTR): detection of immunologically related proteins. J. Cell Sci. 108: 2433-2444 [Abstract]  
• Anderson, M., Welsh, M. (1992). Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 257: 1701-1704 [Abstract]  
• Sharma, M., Benharouga, M., Hu, W., Lukacs, G. L. (2001). Conformational and Temperature-sensitive Stability Defects of the Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments. J. Biol. Chem. 276: 8942-8950 [Abstract] [Full Text]  
• Keller, S. H., Lindstrom, J., Ellisman, M., Taylor, P. (2001). Adjacent Basic Amino Acid Residues Recognized by the COP I Complex and Ubiquitination Govern Endoplasmic Reticulum to Cell Surface Trafficking of the Nicotinic Acetylcholine Receptor alpha -Subunit. J. Biol. Chem. 276: 18384-18391 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents